• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

180.02 +9.03 (+5.28%)
Official Closing Price Updated: 7:00 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 768,792
Open 172.94
Bid (Size) 160.00 (100)
Ask (Size) 180.00 (100)
Prev. Close 170.99
Today's Range 172.22 - 180.62
52wk Range 73.16 - 184.00
Shares Outstanding 55,137,429
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Glaukos (GKOS) Q2 2026 Earnings Call Transcript ↗
August 07, 2026
iDose TR drove $74M in Q2 revenue as Glaukos raised full-year guidance. 
Via The Motley Fool
Topics Earnings
News headline image
Glaukos Q2 Earnings Call Highlights ↗
July 30, 2026
Glaukos (NYSE:GKOS) reported record second-quarter 2026 consolidated net sales of $185.6 million, up 50% from the prior-year period on a reported basis and 49% on a constant-currency basis, as growth... 
Via MarketBeat
Topics Earnings

Performance

YTD
+62.6%
+62.6%
1 Month
+16.1%
+16.1%
3 Month
+33.0%
+33.0%
6 Month
+58.9%
+58.9%
1 Year
+112.7%
+112.7%

More News

Read More
News headline image
Glaukos Announces Second Quarter 2026 Financial Results
July 29, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Completion of Patient Enrollment in 510(k) Pivotal Study for PRESERFLO™ MicroShunt
July 27, 2026
From Glaukos Corporation
Via Business Wire
GKOS (Glaukos Corp) Shows Strong Trend Template Compliance and High Growth Momentum on ChartMill ↗
June 20, 2026
Via Chartmill
Glaukos Corp (NYSE:GKOS) Shares Surge on Record Sales and Raised Guidance After Q1 Beat ↗
April 29, 2026
Via Chartmill
Glaukos Corp (NYSE:GKOS) Shows High-Growth Momentum and Fits Key Trend Template Rules ↗
April 03, 2026
Via Chartmill
News headline image
Glaukos CFO Alex Thurman Sells $1.6 Million in Stock. What Should Investors Do Now? ↗
July 14, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026? ↗
July 08, 2026
Via The Motley Fool
News headline image
Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29
July 08, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis
June 25, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Participation in Upcoming Investor Conferences
May 12, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos (GKOS) Q1 2026 Earnings Transcript ↗
April 29, 2026
Via The Motley Fool
News headline image
Glaukos Announces First Quarter 2026 Financial Results
April 29, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces the Release of its 2025 Sustainability Report
April 16, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Receives Permanent J-code for Epioxa™
April 15, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29
April 08, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
April 06, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care
March 19, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data ↗
February 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗
February 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
February 19, 2026
Via The Motley Fool
News headline image
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗
February 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
BrightSpring Stock Up 86% as Braidwell Takes $45 Million Stake in Healthcare Services Provider ↗
February 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Glaukos (GKOS) Q4 2025 Earnings Call Transcript ↗
February 17, 2026
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is Glaukos Corporation Common Stock publicly traded?
Yes, Glaukos Corporation Common Stock is publicly traded.
What exchange does Glaukos Corporation Common Stock trade on?
Glaukos Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Glaukos Corporation Common Stock?
The ticker symbol for Glaukos Corporation Common Stock is GKOS on the New York Stock Exchange
What is the current price of Glaukos Corporation Common Stock?
The current price of Glaukos Corporation Common Stock is 180.02
When was Glaukos Corporation Common Stock last traded?
The last trade of Glaukos Corporation Common Stock was at 08/07/26 07:00 PM ET
What is the market capitalization of Glaukos Corporation Common Stock?
The market capitalization of Glaukos Corporation Common Stock is 9.93B
How many shares of Glaukos Corporation Common Stock are outstanding?
Glaukos Corporation Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap